| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 46.428.373 $ | 63,04 | 1.191.155 | |||||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 3.433.611 $ | 4,66 | 25.542 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.426.814 $ | 4,65 | 7.657 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 3.301.552 $ | 4,48 | 9.803 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 2.360.755 $ | 3,21 | 3.840 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 1.480.910 $ | 2,01 | 4.904 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.153.698 $ | 1,57 | 7.326 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.063.300 $ | 1,44 | 5.425 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 921.213 $ | 1,25 | 5.653 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 902.048 $ | 1,22 | 1.620 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 883.071 $ | 1,20 | 15.837 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 877.790 $ | 1,19 | 1.050 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 851.859 $ | 1,16 | 7.968 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 793.535 $ | 1,08 | 26.460 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 711.910 $ | 0,97 | 7.359 | |
| Viatris, Inc. | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 692.107 $ | 0,94 | 42.565 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 688.974 $ | 0,94 | 14.600 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 628.997 $ | 0,85 | 4.850 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 587.610 $ | 0,80 | 3.712 | |
| Jazz Pharmaceuticals plc | Jazz Pharmaceuticals plc | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 538.015 $ | 0,73 | 2.275 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 510.074 $ | 0,69 | 2.276 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 502.767 $ | 0,68 | 28.664 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 484.608 $ | 0,66 | 9.600 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 474.885 $ | 0,64 | 7.167 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 469.913 $ | 0,64 | 1.051 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 467.339 $ | 0,63 | 6.109 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 443.167 $ | 0,60 | 1.890 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 421.188 $ | 0,57 | 847 | |
| BioMarin Pharmaceutical, Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 407.332 $ | 0,55 | 7.110 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 404.237 $ | 0,55 | 4.213 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 403.418 $ | 0,55 | 5.178 | |
| Sanofi SA | Sanofi SA | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 395.082 $ | 0,54 | 9.047 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 360.119 $ | 0,49 | 1.029 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 349.488 $ | 0,47 | 4.553 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 340.034 $ | 0,46 | 1.181 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 333.752 $ | 0,45 | 1.080 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 324.219 $ | 0,44 | 6.424 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 301.203 $ | 0,41 | 2.271 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 298.605 $ | 0,41 | 2.705 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 290.381 $ | 0,39 | 4.364 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 285.820 $ | 0,39 | 38.008 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 273.499 $ | 0,37 | 5.321 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 260.017 $ | 0,35 | 6.163 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 250.516 $ | 0,34 | 7.523 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 245.644 $ | 0,33 | 3.017 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 235.061 $ | 0,32 | 2.361 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 226.447 $ | 0,31 | 2.231 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 226.129 $ | 0,31 | 3.062 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 223.096 $ | 0,30 | 2.526 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 213.518 $ | 0,29 | 2.905 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 209.830 $ | 0,28 | 6.002 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 199.439 $ | 0,27 | 3.550 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 194.532 $ | 0,26 | 3.123 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 186.009 $ | 0,25 | 3.773 | |
| Centessa Pharmaceuticals plc | Centessa Pharmaceuticals plc | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 175.858 $ | 0,24 | 4.423 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 174.406 $ | 0,24 | 10.431 | |
| Ligand Pharmaceuticals, Inc. | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 170.723 $ | 0,23 | 736 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 168.240 $ | 0,23 | 3.074 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 166.580 $ | 0,23 | 2.028 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 166.556 $ | 0,23 | 4.624 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 160.837 $ | 0,22 | 3.409 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 153.193 $ | 0,21 | 11.632 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 151.527 $ | 0,21 | 2.266 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 146.941 $ | 0,20 | 11.444 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 143.207 $ | 0,19 | 4.252 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 137.650 $ | 0,19 | 3.872 | |
| ACADIA Pharmaceuticals, Inc. | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 136.523 $ | 0,19 | 6.303 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 136.147 $ | 0,18 | 2.938 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 135.479 $ | 0,18 | 3.966 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 124.047 $ | 0,17 | 3.767 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 123.358 $ | 0,17 | 5.863 | |
| 10X Genomics, Inc. | 10X Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 123.155 $ | 0,17 | 4.351 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 117.662 $ | 0,16 | 6.087 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 113.299 $ | 0,15 | 2.880 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 109.416 $ | 0,15 | 4.978 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 104.710 $ | 0,14 | 1.789 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 103.148 $ | 0,14 | 1.439 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 100.958 $ | 0,14 | 4.674 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 98.437 $ | 0,13 | 4.587 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 98.163 $ | 0,13 | 1.411 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 97.902 $ | 0,13 | 2.120 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 95.660 $ | 0,13 | 3.246 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 93.631 $ | 0,13 | 2.636 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 93.436 $ | 0,13 | 1.573 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 92.814 $ | 0,13 | 6.606 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 92.138 $ | 0,13 | 2.925 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 89.140 $ | 0,12 | 3.685 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 86.896 $ | 0,12 | 2.196 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 86.234 $ | 0,12 | 5.692 | |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 85.490 $ | 0,12 | 3.571 | |
| Legend Biotech Corp. | Legend Biotech Corp. | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 84.794 $ | 0,12 | 3.122 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 82.781 $ | 0,11 | 2.255 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 82.605 $ | 0,11 | 9.271 | |
| Kiniksa Pharmaceuticals International plc | Kiniksa Pharmaceuticals International plc, Class A | EC | GB00BRXB0C07 | Long | Börsenkurs (Stufe 1) | 82.149 $ | 0,11 | 1.698 | |
| Aurinia Pharmaceuticals, Inc. | Aurinia Pharmaceuticals, Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 75.332 $ | 0,10 | 4.914 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 72.521 $ | 0,10 | 8.049 | |
| Novocure Ltd. | Novocure Ltd. | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 71.721 $ | 0,10 | 4.209 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 71.389 $ | 0,10 | 2.367 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 70.696 $ | 0,10 | 1.651 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 70.264 $ | 0,10 | 8.805 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 69.678 $ | 0,09 | 1.764 | |
| Zymeworks, Inc. | Zymeworks, Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 69.510 $ | 0,09 | 2.766 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 69.276 $ | 0,09 | 19.297 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 69.246 $ | 0,09 | 3.875 | |
| AbCellera Biologics, Inc. | AbCellera Biologics, Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 69.160 $ | 0,09 | 11.209 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 67.603 $ | 0,09 | 2.140 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 67.524 $ | 0,09 | 3.802 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 67.052 $ | 0,09 | 4.742 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 66.072 $ | 0,09 | 6.023 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 65.951 $ | 0,09 | 1.974 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 65.762 $ | 0,09 | 2.305 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 65.251 $ | 0,09 | 2.111 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 65.163 $ | 0,09 | 830 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 63.883 $ | 0,09 | 3.261 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 63.680 $ | 0,09 | 2.166 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 62.639 $ | 0,09 | 2.379 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 62.494 $ | 0,08 | 1.875 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 62.451 $ | 0,08 | 15.232 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 61.472 $ | 0,08 | 4.369 | |
| AtaiBeckley, Inc. | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 60.833 $ | 0,08 | 13.429 | |
| Taysha Gene Therapies, Inc. | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 59.451 $ | 0,08 | 10.128 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 58.691 $ | 0,08 | 2.740 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 58.247 $ | 0,08 | 4.059 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 56.950 $ | 0,08 | 1.023 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 56.767 $ | 0,08 | 13.080 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 55.853 $ | 0,08 | 537 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 55.543 $ | 0,08 | 2.818 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 55.427 $ | 0,08 | 5.810 | |
| GH Research plc | GH Research plc | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 55.033 $ | 0,07 | 2.294 | |
| Ardelyx, Inc. | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 54.759 $ | 0,07 | 9.066 | |
| Fortrea Holdings, Inc. | Fortrea Holdings, Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 53.172 $ | 0,07 | 3.455 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 52.177 $ | 0,07 | 1.658 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 50.960 $ | 0,07 | 2.343 | |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 50.247 $ | 0,07 | 1.870 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 50.041 $ | 0,07 | 1.657 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | IL0011407140 | Long | Börsenkurs (Stufe 1) | 48.665 $ | 0,07 | 1.730 | |
| Harrow, Inc. | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 48.238 $ | 0,07 | 1.370 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 47.046 $ | 0,06 | 1.778 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 46.831 $ | 0,06 | 1.621 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 46.222 $ | 0,06 | 1.527 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 45.797 $ | 0,06 | 6.960 | |
| Compass Pathways plc | Compass Pathways plc | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 45.540 $ | 0,06 | 3.487 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 44.107 $ | 0,06 | 3.869 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 42.937 $ | 0,06 | 11.389 | |
| EyePoint, Inc. | EyePoint, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 41.582 $ | 0,06 | 3.062 | |
| Alvotech SA | Alvotech SA | EC | LU2458332611 | Long | Börsenkurs (Stufe 1) | 41.026 $ | 0,06 | 12.210 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 39.391 $ | 0,05 | 1.172 | |
| Savara, Inc. | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 39.125 $ | 0,05 | 7.524 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 39.069 $ | 0,05 | 2.962 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 37.900 $ | 0,05 | 3.054 | |
| Xeris Biopharma Holdings, Inc. | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 37.785 $ | 0,05 | 6.134 | |
| Absci Corp. | Absci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 37.537 $ | 0,05 | 5.561 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 36.487 $ | 0,05 | 1.983 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 35.921 $ | 0,05 | 2.185 | |
| Grifols SA | Grifols SA | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 35.404 $ | 0,05 | 4.510 | |
| Pacira BioSciences, Inc. | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 34.714 $ | 0,05 | 1.495 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 33.160 $ | 0,05 | 3.656 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 32.842 $ | 0,04 | 2.251 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 32.824 $ | 0,04 | 3.218 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 32.502 $ | 0,04 | 9.849 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 32.422 $ | 0,04 | 7.110 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 32.207 $ | 0,04 | 2.711 | |
| MeiraGTx Holdings plc | MeiraGTx Holdings plc | EC | KYG596651029 | Long | Börsenkurs (Stufe 1) | 31.684 $ | 0,04 | 2.975 | |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 31.611 $ | 0,04 | 1.677 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 31.358 $ | 0,04 | 3.711 | |
| Eton Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 30.206 $ | 0,04 | 992 | |
| Theravance Biopharma, Inc. | Theravance Biopharma, Inc. | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 30.113 $ | 0,04 | 1.875 | |
| Mesoblast Ltd. | Mesoblast Ltd. | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 29.784 $ | 0,04 | 1.934 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 29.503 $ | 0,04 | 23.602 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 28.992 $ | 0,04 | 5.349 | |
| Omeros Corp. | Omeros Corp. | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 28.947 $ | 0,04 | 2.622 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 27.926 $ | 0,04 | 2.912 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 27.733 $ | 0,04 | 1.604 | |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 27.660 $ | 0,04 | 8.837 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 26.531 $ | 0,04 | 3.053 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 25.968 $ | 0,04 | 5.410 | |
| CorMedix, Inc. | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 24.569 $ | 0,03 | 2.911 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 24.142 $ | 0,03 | 2.083 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 23.689 $ | 0,03 | 6.673 | |
| Phibro Animal Health Corp. | Phibro Animal Health Corp., Class A | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 23.493 $ | 0,03 | 763 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 23.188 $ | 0,03 | 1.100 | |
| Vor BioPharma, Inc. | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 22.994 $ | 0,03 | 1.536 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 22.554 $ | 0,03 | 6.265 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 22.468 $ | 0,03 | 2.707 | |
| Zai Lab Ltd. | Zai Lab Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 22.449 $ | 0,03 | 1.269 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 22.060 $ | 0,03 | 2.105 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 21.597 $ | 0,03 | 693 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc., Class A | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 21.520 $ | 0,03 | 6.028 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 21.220 $ | 0,03 | 2.363 | |
| Solid Biosciences, Inc. | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 21.139 $ | 0,03 | 2.880 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 20.489 $ | 0,03 | 672 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 20.288 $ | 0,03 | 4.459 | |
| Prothena Corp. plc | Prothena Corp. plc | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 20.248 $ | 0,03 | 1.989 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 18.680 $ | 0,03 | 1.885 | |
| Aquestive Therapeutics, Inc. | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 18.134 $ | 0,02 | 4.511 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 18.028 $ | 0,02 | 8.308 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 17.994 $ | 0,02 | 2.112 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 17.547 $ | 0,02 | 2.349 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 17.051 $ | 0,02 | 2.464 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 16.695 $ | 0,02 | 1.997 | |
| Kamada Ltd. | Kamada Ltd. | EC | IL0010941198 | Long | Börsenkurs (Stufe 1) | 16.667 $ | 0,02 | 2.134 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 16.633 $ | 0,02 | 11.163 | |
| First Tracks Biotherapeutics, Inc. | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 16.327 $ | 0,02 | 1.023 | |
| Neurogene, Inc. | Neurogene, Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 16.182 $ | 0,02 | 571 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 15.771 $ | 0,02 | 3.609 | |
| Evolus, Inc. | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 15.724 $ | 0,02 | 2.397 | |
| Lakefront Biotherapeutics NV | Lakefront Biotherapeutics NV | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 15.536 $ | 0,02 | 548 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 15.163 $ | 0,02 | 1.124 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 14.369 $ | 0,02 | 5.322 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 14.125 $ | 0,02 | 4.631 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 14.108 $ | 0,02 | 1.072 | |
| Vanda Pharmaceuticals, Inc. | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 14.100 $ | 0,02 | 2.186 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 13.969 $ | 0,02 | 4.014 | |
| Autolus Therapeutics plc | Autolus Therapeutics plc | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 13.864 $ | 0,02 | 7.414 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 13.863 $ | 0,02 | 2.697 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 13.773 $ | 0,02 | 2.387 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 13.639 $ | 0,02 | 787 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 13.492 $ | 0,02 | 2.889 | |
| Puma Biotechnology, Inc. | Puma Biotechnology, Inc. | EC | 74587V107 | Long | Börsenkurs (Stufe 1) | 13.472 $ | 0,02 | 1.879 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 13.445 $ | 0,02 | 3.557 | |
| REGENXBIO, Inc. | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 13.130 $ | 0,02 | 1.873 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 12.656 $ | 0,02 | 1.125 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 12.494 $ | 0,02 | 3.611 | |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | EC | 826917106 | Long | Börsenkurs (Stufe 1) | 12.383 $ | 0,02 | 2.646 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 12.320 $ | 0,02 | 4.013 | |
| Silence Therapeutics plc | Silence Therapeutics plc | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 11.978 $ | 0,02 | 1.736 | |
| Invivyd, Inc. | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 11.678 $ | 0,02 | 10.244 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 11.426 $ | 0,02 | 6.176 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 10.697 $ | 0,01 | 1.981 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 10.381 $ | 0,01 | 3.426 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 10.011 $ | 0,01 | 1.416 | |
| AC Immune SA | AC Immune SA | EC | CH0329023102 | Long | Börsenkurs (Stufe 1) | 9.898 $ | 0,01 | 3.721 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 9.277 $ | 0,01 | 7.136 | |
| Foghorn Therapeutics, Inc. | Foghorn Therapeutics, Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 9.266 $ | 0,01 | 2.165 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 9.255 $ | 0,01 | 3.341 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 9.009 $ | 0,01 | 1.158 | |
| Coherus Oncology, Inc. | Coherus Oncology, Inc. | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 8.785 $ | 0,01 | 5.525 | |
| Quantum-Si, Inc. | Quantum-Si, Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 8.604 $ | 0,01 | 7.230 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 8.433 $ | 0,01 | 2.179 | |
| Sagimet Biosciences, Inc. | Sagimet Biosciences, Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 8.362 $ | 0,01 | 1.147 | |
| Arcturus Therapeutics Holdings, Inc. | Arcturus Therapeutics Holdings, Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 8.332 $ | 0,01 | 1.052 | |
| Orchestra BioMed Holdings, Inc. | Orchestra BioMed Holdings, Inc. | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 8.168 $ | 0,01 | 2.089 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 8.151 $ | 0,01 | 3.454 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 8.025 $ | 0,01 | 1.711 | |
| NovaBridge Biosciences | NovaBridge Biosciences | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 7.638 $ | 0,01 | 4.151 | |
| Lifecore Biomedical, Inc. | Lifecore Biomedical, Inc. | EC | 514766104 | Long | Börsenkurs (Stufe 1) | 6.963 $ | 0,01 | 1.387 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 6.962 $ | 0,01 | 8.012 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | KYG831161065 | Long | Börsenkurs (Stufe 1) | 6.035 $ | 0,01 | 2.743 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 4.673 $ | 0,01 | 2.105 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 4.145 $ | 0,01 | 2.303 | |
| PepGen, Inc. | PepGen, Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 3.812 $ | 0,01 | 2.541 | |
| Rani Therapeutics Holdings, Inc. | Rani Therapeutics Holdings, Inc., Class A | EC | 753018100 | Long | Börsenkurs (Stufe 1) | 3.430 $ | 0,00 | 3.608 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 3.304 $ | 0,00 | 804 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 1.975 $ | 0,00 | 8.555 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 1.662 | |
| 46.428.373 $ | 63,04 | 1.191.155 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.